refractory ALCL

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . relapsed refractory AML . hormone refractory prostate cancer . refractory anemia . rituximab refractory follicular / ALCLS : Cellectis Alternext ALCLS . Cellectis SA Alternext ALCLS . cell lymphoma ALCL . refractory systemic ALCL . systemic ALCL . systemic ALCL patients * *

Related by context. Frequent words. (Click for all words.) 64 refractory Hodgkin lymphoma 62 refractory PTCL 59 refractory multiple myeloma 57 relapsed refractory multiple myeloma 56 relapsed multiple myeloma 55 metastatic renal cell carcinoma 55 CR# vcMMAE 54 PegIntron 54 Jevtana 54 Taxotere ® 54 ponatinib 54 Torisel 54 Amrubicin 54 glufosfamide 53 valopicitabine 53 anticancer therapy 53 abiraterone acetate 53 tipranavir 53 relapsed 53 allogeneic stem cell 53 axitinib 53 refractory peripheral T 53 temsirolimus 53 therapeutic regimens 53 biologic therapy 53 GVAX 52 lymphoma CTCL 52 neoadjuvant therapy 52 nalmefene 52 dasatinib 52 plus prednisone 52 castration resistant prostate cancer 52 vinorelbine 52 HGS ETR1 52 plus gemcitabine 52 Trastuzumab 52 CoFactor 52 HER2 positive metastatic breast 52 sustained virologic response 51 dacarbazine 51 pancreatic insufficiency 51 acamprosate 51 interferon therapy 51 virologic failure 51 peginterferon 51 alvimopan 51 nab paclitaxel 51 relapsing MS 51 secondary hyperparathyroidism 51 vandetanib 51 tesmilifene 51 eltrombopag 51 topotecan 51 eribulin 51 nilotinib 51 pazopanib 51 azacitidine 51 PXD# 51 abiraterone 51 phase IIa 51 tocilizumab 51 PEG INTRON 51 BAY #-# 51 Marqibo 50 chronic angina 50 Xyotax 50 Genasense 50 relapse 50 cytogenetic response 50 ocrelizumab 50 pharmacological treatments 50 Mylotarg 50 FOLFIRI 50 thiazolidinedione 50 HRPC 50 antidepressant therapy 50 nortriptyline 50 gastrointestinal stromal tumors 50 Combination therapy 50 tanespimycin 50 mirtazapine 50 active comparator 50 neoadjuvant 50 pseudobulbar affect PBA 50 tumor shrinkage 50 Pixantrone 49 Telcyta 49 nitazoxanide 49 taxane 49 KNS # 49 Alemtuzumab 49 FOLOTYN 49 Irinotecan 49 Phase 2a trial 49 Fludara 49 stable angina 49 annualized relapse 49 TORISEL 49 interferon alfa 49 pemetrexed 49 registrational

Back to home page